Trabectedin Combined with Durvalumab

Elodie_Espesset March 21, 2017, 9:43pm 1

A new trial in France will test the combination of Trabectedin (aka Yondelis) and Durvalumab, a monoclonal antibody targeting PD-L1:

Topic		Replies	Views
Trabectedin Success? side effects? more promising options? Treatment Options	16	3495	April 9, 2015
Tribectedin Clinical Trial Personal Experience with Clinical Trials	3	2178	November 7, 2011
Trabectedin (Yondelis) In Advanced Synovial Sarcoma, Retrospective Study from Europe Clinical Trials and Research Updates	2	2333	March 14, 2017
Trabectedin Sensitivity Blog	0	229	March 26, 2011
Sunitinib (Sutent) Plus Nivolumab (Opdivo) Clinical Trials and Research Updates	0	1874	September 15, 2017